MinichMacGregor Wealth Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,415
| Closed | -$315K | – | 109 |
|
|
2024
Q1 | $315K | Buy |
7,415
+50
| +0.7% | +$2.12K | 0.08% | 83 |
|
|
2023
Q4 | $273K | Hold |
7,365
| – | – | 0.08% | 85 |
|
|
2023
Q3 | $267K | Hold |
7,365
| – | – | 0.09% | 78 |
|
|
2023
Q2 | $262K | Hold |
7,365
| – | – | 0.08% | 79 |
|
|
2023
Q1 | $262K | Buy |
7,365
+7,300
| +11,231% | +$260K | 0.09% | 79 |
|
|
2022
Q4 | $2.28K | Buy |
+65
| New | +$2.28K | ﹤0.01% | 557 |
|
|
2018
Q4 | – | Sell |
-285
| Closed | -$14K | – | 252 |
|
|
2018
Q3 | $14K | Sell |
285
-108
| -27% | -$5.31K | 0.01% | 270 |
|
|
2018
Q2 | $19K | Buy |
393
+113
| +40% | +$5.46K | 0.01% | 219 |
|
|
2018
Q1 | $13K | Buy |
280
+2
| +0.7% | +$93 | 0.01% | 266 |
|
|
2017
Q4 | $12K | Buy |
278
+3
| +1% | +$129 | 0.01% | 276 |
|
|
2017
Q3 | $13K | Buy |
275
+1
| +0.4% | +$47 | 0.01% | 243 |
|
|
2017
Q2 | $14K | Buy |
274
+3
| +1% | +$153 | 0.01% | 231 |
|
|
2017
Q1 | $14K | Sell |
271
-94
| -26% | -$4.86K | 0.01% | 227 |
|
|
2016
Q4 | $17K | Buy |
365
+2
| +0.6% | +$93 | 0.02% | 192 |
|
|
2016
Q3 | $19K | Hold |
363
| – | – | 0.02% | 187 |
|
|
2016
Q2 | $19K | Buy |
363
+2
| +0.6% | +$105 | 0.02% | 180 |
|
|
2016
Q1 | $18K | Buy |
361
+7
| +2% | +$349 | 0.02% | 185 |
|
|
2015
Q4 | $19K | Buy |
+354
| New | +$19K | 0.02% | 167 |
|